Clinical trial
Oxytocin Treatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Study of Safety and Efficacy on Oral and Social Skills and Feeding Behavior of Intranasal Administration of Oxytocin vs Placebo
NCT04283578 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oxytocin Treatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Study of Safety and Efficacy on Oral and Social Skills and Feeding Behavior of Intranasal Administration of Oxytocin vs Placebo
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 10, 2020
- Completion date
- March 14, 2022
- Enrollment
- 52 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.